GILEAD SCIENCES 885823 (Seite 333)
eröffnet am 20.02.06 13:18:36 von
neuester Beitrag 13.02.24 21:17:08 von
neuester Beitrag 13.02.24 21:17:08 von
Beiträge: 3.632
ID: 1.041.671
ID: 1.041.671
Aufrufe heute: 9
Gesamt: 481.750
Gesamt: 481.750
Aktive User: 0
ISIN: US3755581036 · WKN: 885823 · Symbol: GILD
61,80
EUR
+1,18 %
+0,72 EUR
Letzter Kurs 12:48:09 Tradegate
Neuigkeiten
| Gilead Sciences Aktien ab 5,80 Euro handeln - Ohne versteckte Kosten!Anzeige |
30.04.24 · Business Wire (engl.)  |
30.04.24 · Shareribs Anzeige |
26.04.24 · Shareribs Anzeige |
26.04.24 · Business Wire (engl.) |
Werte aus der Branche Pharmaindustrie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 1,2000 | +471,16 | |
| 13,110 | +38,44 | |
| 1,1514 | +30,84 | |
| 1,1040 | +22,53 | |
| 0,9150 | +21,84 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 9,5800 | -11,71 | |
| 4,5001 | -13,46 | |
| 46,00 | -19,44 | |
| 36,70 | -22,87 | |
| 2,7280 | -29,14 |
Beitrag zu dieser Diskussion schreiben
Feedback
Gibt es News die den Kurs so steigen lassen?
Hebel-Hertel kurz vor Weihnachten:
http://www.godmode-trader.de/nachricht/GILEAD-Trendbruch-fue…
früher sagte der Lehrer: 6,setzen !
http://www.godmode-trader.de/nachricht/GILEAD-Trendbruch-fue…
früher sagte der Lehrer: 6,setzen !
RBC Capital Markets stuft Gilead Sciences auf outperform
http://www.wallstreet-online.de/nachricht/4404819-rbc-capita…
Rating: outperform
Analyst: RBC Capital Markets
Kursziel: 56 US-Dollar
http://www.wallstreet-online.de/nachricht/4404819-rbc-capita…
Rating: outperform
Analyst: RBC Capital Markets
Kursziel: 56 US-Dollar
Stuttgart:
Geld 31,395
Brief 31,73
Zeit 02.01.1211:04:47
Frankfurt
Geld 31,553
Brief 31,633
Zeit 02.01.1211:01:56
Geld 31,395
Brief 31,73
Zeit 02.01.1211:04:47
Frankfurt
Geld 31,553
Brief 31,633
Zeit 02.01.1211:01:56
in Stuttgart wird kommisch gepreist kurs springt im Minutentakt.
Trading Spotlight
We looked at the Healthcare sector and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at today's price action of all companies in this peer group.
Gilead Sciences (NASDAQ:GILD) ranks first with a gain of 0.35%; Zimmer (NYSE:ZMH) ranks second with a gain of 0.06%; and Mylan (NASDAQ:MYL) ranks third with a loss of 0.05%.
Bristol-Myers Squibb (NYSE:BMY) follows with a loss of 0.18% and Amgen (NASDAQ:AMGN) rounds out the top five with a loss of 0.26%.
SmarTrend recommended that subscribers consider buying shares of Amgen on December 7th, 2011 as our technology indicated a new Uptrend was in progress when shares hit $58.13. Since that recommendation, shares of Amgen have risen 10.8%. We continue to monitor Amgen for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.
Gilead Sciences (NASDAQ:GILD) ranks first with a gain of 0.35%; Zimmer (NYSE:ZMH) ranks second with a gain of 0.06%; and Mylan (NASDAQ:MYL) ranks third with a loss of 0.05%.
Bristol-Myers Squibb (NYSE:BMY) follows with a loss of 0.18% and Amgen (NASDAQ:AMGN) rounds out the top five with a loss of 0.26%.
SmarTrend recommended that subscribers consider buying shares of Amgen on December 7th, 2011 as our technology indicated a new Uptrend was in progress when shares hit $58.13. Since that recommendation, shares of Amgen have risen 10.8%. We continue to monitor Amgen for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.
41 schon erreicht aber wieder zurück
GILEAD - Abwärtstrend wird attackiert
http://www.wallstreet-online.de/nachricht/4134055-gilead-abw…
http://www.wallstreet-online.de/nachricht/4134055-gilead-abw…
Durchsuchen
